FIELD: medicine.
SUBSTANCE: invention relates to new compounds of the formula I, in which R1 is unsubstituted C(1-6) alkyl, and R2 and R3 are independently linear unsubstituted C(4-30) alkyl. Methods for the treatment of a subject by the injection of the compound of the formula I to the specified subject are also proposed. Pharmaceutical and food compositions containing one or more of the specified esters are also proposed.
EFFECT: obtaining esters of beta-hydroxybutyrate and butanediol formed by medium-chain fatty acids.
Formula I
31 cl, 12 ex, 19 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR ELEVATING AND SUSTAINING KETOSIS | 2014 |
|
RU2659386C2 |
KETOGENIC COMPOSITION | 2021 |
|
RU2769242C1 |
METHOD FOR STRUCTURAL AND/OR FUNCTIONAL IMPROVEMENT OF ARTERIOLES | 2005 |
|
RU2414236C2 |
THERAPEUTIC COMPOSITIONS (U) | 1999 |
|
RU2242227C2 |
BLOCKING OF INFLAMMATORY PROTEASES BY THETA-DEFENSINS | 2012 |
|
RU2652605C2 |
EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND RADIOTHERAPY: COMPOSITIONS AND USE | 2007 |
|
RU2512491C2 |
NEW DERIVATIVES OF CYP-EICOSANOIDS | 2015 |
|
RU2730512C2 |
SULPHONAMIDE COMPOUNDS AND USE THEREOF AS STAT5 INHIBITORS | 2015 |
|
RU2707094C2 |
METHODS FOR TREATMENT AND PREVENTION OF AGE-RELATED DYSFUNCTION OF RETINA | 2009 |
|
RU2565448C2 |
NIACIN MIMETICS AND METHOD FOR USE THEREOF | 2011 |
|
RU2588133C2 |
Authors
Dates
2021-12-13—Published
2017-06-02—Filed